follicular lymphoma
Rituximab for follicular lymphoma: maintaining an open mind
New data from the Primary Rituximab And Maintenance study provide the strongest support for the use of rituximab maintenance in patients with follicular lymphoma. However, further considerations of cost, inconvenience, toxic effects, efficacy of retreatment [more]
Is rituximab maintenance therapy useful following rituximab salvage in refractory or relapsed follicular lymphoma?
A study by the German Low Grade Lymphoma Study Group has shown that rituximab maintenance following salvage with rituximab-containing chemotherapy is the standard of care for advanced-stage refractory or relapsed follicular lymphoma. Download full article
Follicular lymphoma: side-lined drug excites new interest
A study showing that follicular lymphoma patients benefit from adding interferon to standard chemotherapy has opened up new avenues for research. Download full article